MedTrace Logo

Prehypertension Labeling

NCT01434953 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2017-07-17

No results posted yet for this study

Summary

The purpose of this study is to find out whether labeling adults with prehypertension has negative effects on clinic blood pressure and quality of life 3 months after diagnosis.

Conditions

  • Prehypertension

Interventions

BEHAVIORAL

Labeled prehypertension

A study physician informs subjects of their blood pressure level. Subjects are told they have prehypertension and are informed of the associated health risks.

BEHAVIORAL

Unlabeled prehypertension

A study physician informs subjects of their blood pressure level. The term "prehypertension" is not used and associated health risks are not discussed.

Sponsors & Collaborators

Principal Investigators

  • Matthew Burg, MD · Columbia University

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-07-13
Primary Completion
2012-07-09
Completion
2012-07-09

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01434953 on ClinicalTrials.gov